CPIX: Cumberland Pharmaceuticals Inc. Stock

by  •  • Comments Off on CPIX: Cumberland Pharmaceuticals Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 83.55
Enterprise Value ($M) 81.87
Book Value ($M) 24.47
Book Value / Share 1.74
Price / Book 3.41
NCAV ($M) -17.04
NCAV / Share -1.21
Price / NCAV -4.90

Profitability (mra)
Return on Invested Capital (ROIC) -0.24
Return on Assets (ROA) -0.13
Return on Equity (ROE) -0.37

Liquidity (mrq)
Quick Ratio 0.99
Current Ratio 1.13

Balance Sheet (mrq) ($M)
Current Assets 35.24
Assets 76.75
Liabilities 52.28
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G Kazimi A J
02-11 13G Integrated Core Strategies (us) Llc
2024-02-09 13G Cumberland Pharmaceuticals Inc 40.14 -1.24

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-13 10-K ____________________________________________________________________________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 12,355 162,796 7.59
2025-02-20 71,484 289,959 24.65
2025-02-19 361,511 1,467,097 24.64
2025-02-18 54,906 213,914 25.67

(click for more detail)

Similar Companies
CGON – CG Oncology, Inc. COGT – Cogent Biosciences, Inc.
COLL – Collegium Pharmaceutical, Inc. CRBU – Caribou Biosciences, Inc.
CRGX – CARGO Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io